Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation-Reference-Cited by-同舟云学术

Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation

Published:2018-05 Issue:5 Volume:32 Page:e13244
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Kim Hyeyoung¹²,Yi Nam-Joon¹^ORCID,Song Eun Young³^ORCID,Lee Kyoungbun⁴,Lee Kwang-Woong¹,Lee Hae Won¹²,Ahn Hye Young¹,Yoon Kyung Chul¹,Hong Suk Kyun¹,Suh Kyung-Suk¹

Affiliation:

1. Department of Surgery; Seoul National University College of Medicine; Seoul Korea

2. Department of Surgery; Seoul Metropolitan Government - Seoul National University Boramae Medical Center; Seoul Korea

3. Department of Laboratory Medicine; Seoul National University College of Medicine; Seoul Korea

4. Department of Pathology; Seoul National University College of Medicine; Seoul Korea

Funder

Korean Society for Transplantation

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.13244/fullpdf

Reference36 articles.

1. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation;Cuadrado;World J Gastroenterol,2015

2. Antibody-mediated rejection in liver transplantation: current controversies and future directions;Taner;Liver Transpl,2014

3. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility;Castillo-Rama;Liver Transpl,2008

4. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies;Kozlowski;Liver Transpl,2011

5. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss;O'Leary;Liver Transpl,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The fate of anti-HLA antibodies following liver transplantation;Frontiers in Nephrology;2024-06-12

2. Impact of Preformed Donor-specific Antibodies in Comparison to ABO Incompatibility in Living Donor Liver Transplantation: A Propensity Score–Matched Analysis;Transplantation;2024-03-29

3. Liver transplantation: the recipient;Living Donor Organ Transplantation;2024

4. Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience;Annals of Transplantation;2023-10-27

5. Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation;Korean Journal of Transplantation;2023-09-11